{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:38:11Z","timestamp":1786981091442,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s10815-017-0990-7","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T05:17:31Z","timestamp":1500009451000},"page":"1341-1351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study"],"prefix":"10.1007","volume":"34","author":[{"given":"Theoni B","family":"Tarlatzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos A","family":"Venetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Devreker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvon","family":"Englert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Delbaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"key":"990_CR1","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/humrep\/deu175","volume":"29","author":"MS Kupka","year":"2014","unstructured":"Kupka MS, Ferraretti AP, de Mouzon J, Erb K, D\u2019Hooghe T, Castilla JA, et al. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE\u2020. Hum Reprod. 2014;29:2099\u2013113.","journal-title":"Hum Reprod"},{"key":"990_CR2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","volume":"85","author":"EG Papanikolaou","year":"2005","unstructured":"Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2005;85:112\u201320.","journal-title":"Fertil Steril"},{"key":"990_CR3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/oxfordjournals.humrep.a137223","volume":"5","author":"J Smitz","year":"1990","unstructured":"Smitz J, Camus M, Devroey P, Erard P, Wisanto A, Van Steirteghem AC. Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist\/HMG superovulation for in-vitro fertilization. Hum Reprod. 1990;5:933\u20137.","journal-title":"Hum Reprod"},{"key":"990_CR4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.rbmo.2012.01.005","volume":"24","author":"BC Tarlatzis","year":"2012","unstructured":"Tarlatzis BC, Griesinger G, Leader A, Rombauts L, Ijzerman-Boon PC, BMJL M. Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH. Reprod BioMed Online. 2012;24:410\u20139.","journal-title":"Reprod BioMed Online"},{"key":"990_CR5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/humupd\/dmg018","volume":"9","author":"MA Aboulghar","year":"2003","unstructured":"Aboulghar MA, Mansour RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update. 2003;9:275\u201389.","journal-title":"Hum Reprod Update"},{"key":"990_CR6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","volume":"58","author":"D Navot","year":"1992","unstructured":"Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril. 1992;58:249\u201361.","journal-title":"Fertil Steril"},{"key":"990_CR7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ncpendmet0319","volume":"2","author":"A Delbaere","year":"2006","unstructured":"Delbaere A, Smits G, Vassart G, Costagliola S. Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization. Nat Clin Pract Endocrinol Metab. 2006;2:590\u20131.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"990_CR8","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1210\/jc.2004-1044","volume":"89","author":"C Daelemans","year":"2004","unstructured":"Daelemans C, Smits G, de Maertelaer V, Costagliola S, Englert Y, Vassart G, et al. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab. 2004;89:6310\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"990_CR9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1385\/ENDO:26:3:285","volume":"26","author":"A Delbaere","year":"2005","unstructured":"Delbaere A, Smits G, De Leener A, Costagliola S, Vassart G. Understanding ovarian hyperstimulation syndrome. Endocrine. 2005;26:285\u201390.","journal-title":"Endocrine"},{"key":"990_CR10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0015-0282(16)55459-4","volume":"58","author":"MA Aboulghar","year":"1992","unstructured":"Aboulghar MA, Mansour RT, Serour GI. Pathophysiology of ovarian hyperstimulation syndrome. Fertil Steril. 1992;58:449\u201351.","journal-title":"Fertil Steril"},{"key":"990_CR11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0015-0282(16)56997-0","volume":"62","author":"A Delbaere","year":"1994","unstructured":"Delbaere A, Bergmann PJ, Gervy-Decoster C, Staroukine M, Englert Y. Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management. Fertil Steril. 1994;62:731\u20137.","journal-title":"Fertil Steril"},{"key":"990_CR12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/humrep\/12.2.236","volume":"12","author":"A Delbaere","year":"1997","unstructured":"Delbaere A, Bergmann PJ, Gervy-Decoster C, Camus M, de Maertelaer V, Englert Y. Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome. Hum Reprod. 1997;12:236\u201340.","journal-title":"Hum Reprod"},{"key":"990_CR13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/humrep\/deh124","volume":"19","author":"A Delbaere","year":"2004","unstructured":"Delbaere A, Smits G, Olatunbosun O, Pierson R, Vassart G, Costagliola S. New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome? Hum Reprod. 2004;19:486\u20139.","journal-title":"Hum Reprod"},{"key":"990_CR14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/14647273.2013.831996","volume":"16","author":"I Evbuomwan","year":"2013","unstructured":"Evbuomwan I. The role of osmoregulation in the pathophysiology and management of severe ovarian hyperstimulation syndrome. Hum Fertil (Camb). 2013;16:162\u20137.","journal-title":"Hum Fertil (Camb)"},{"key":"990_CR15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/oxfordjournals.humrep.a138598","volume":"9","author":"CA Lyons","year":"1994","unstructured":"Lyons CA, Wheeler CA, Frishman GN, Hackett RJ, Seifer DB, Haning RV. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod. 1994;9:792\u20139.","journal-title":"Hum Reprod"},{"key":"990_CR16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0015-0282(00)00492-1","volume":"73","author":"RS Mathur","year":"2000","unstructured":"Mathur RS, Akande AV, Keay SD, Hunt LP, Jenkins JM. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril. 2000;73:901\u20137.","journal-title":"Fertil Steril"},{"key":"990_CR17","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/humrep\/deg208","volume":"18","author":"M Aboulghar","year":"2003","unstructured":"Aboulghar M. Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS. Hum Reprod. 2003;18:1140\u20131.","journal-title":"Hum Reprod"},{"key":"990_CR18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/oxfordjournals.humrep.a136044","volume":"10","author":"RS Morris","year":"1995","unstructured":"Morris RS, Paulson RJ, Sauer MV, Lobo RA. Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome. Hum Reprod. 1995;10:811\u20134.","journal-title":"Hum Reprod"},{"key":"990_CR19","doi-asserted-by":"crossref","unstructured":"Balen AH, Braat D, West C, Patel A, Jacobs HS. Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients. Hum Reprod. 1994;","DOI":"10.1093\/oxfordjournals.humrep.a138750"},{"key":"990_CR20","doi-asserted-by":"crossref","unstructured":"D\u2019Angelo A, Brown J, Amso NN. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev. 2011;:CD002811.","DOI":"10.1002\/14651858.CD002811.pub3"},{"key":"990_CR21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0030-1265674","volume":"28","author":"S Kashyap","year":"2010","unstructured":"Kashyap S, Parker K, Cedars MI, Rosenwaks Z. Ovarian hyperstimulation syndrome prevention strategies: reducing the human chorionic gonadotropin trigger dose. Semin Reprod Med. 2010;28:475\u201385.","journal-title":"Semin Reprod Med"},{"key":"990_CR22","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/oxfordjournals.humrep.a137798","volume":"7","author":"I Wada","year":"1992","unstructured":"Wada I, Matson PL, Horne G, Buck P, Lieberman BA. Is continuation of a gonadotrophin-releasing hormone agonist (GnRHa) necessary for women at risk of developing the ovarian hyperstimulation syndrome? Hum Reprod. 1992;7:1090\u20133.","journal-title":"Hum Reprod"},{"key":"990_CR23","doi-asserted-by":"crossref","unstructured":"Salat-Baroux J, Alvarez S, Antoine JM, Cornet D. Treatment of hyperstimulation during in-vitro fertilization. Hum Reprod. Oxford University Press; 1990.","DOI":"10.1093\/oxfordjournals.humrep.a137036"},{"key":"990_CR24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.fertnstert.2010.05.026","volume":"95","author":"CA Venetis","year":"2011","unstructured":"Venetis CA, Kolibianakis EM, Toulis KA, Goulis DG, Papadimas I, Tarlatzis BC. Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis. Fertil. Steril. 2011;95:188\u201396\u2013196.e1\u20133.","journal-title":"Fertil. Steril"},{"key":"990_CR25","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/humrep\/12.12.2599","volume":"12","author":"MA Graf","year":"1997","unstructured":"Graf MA, Fischer R, Naether OG, Baukloh V, Tafel J, N\u00fcckel M. Reduced incidence of ovarian hyperstimulation syndrome by prophylactic infusion of hydroxyaethyl starch solution in an in-vitro fertilization programme. Hum Reprod. 1997;12:2599\u2013602.","journal-title":"Hum Reprod"},{"key":"990_CR26","first-page":"CD008605\u20135","volume":"2","author":"H Tang","year":"2012","unstructured":"Tang H, Hunter T, Hu Y, Zhai S-D, Sheng X, Hart RJ. Cabergoline for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev. 2012;2:CD008605\u20135.","journal-title":"Cochrane Database Syst Rev"},{"key":"990_CR27","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1093\/humrep\/dep246","volume":"24","author":"P Humaidan","year":"2009","unstructured":"Humaidan P, Papanikolaou EG, Tarlatzis BC. GnRHa to trigger final oocyte maturation: a time to reconsider. Hum Reprod. 2009;24:2389\u201394.","journal-title":"Hum Reprod"},{"key":"990_CR28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jcem.87.2.8197","volume":"87","author":"BC Fauser","year":"2002","unstructured":"Fauser BC, de Jong D, Olivennes F, Wramsby H, Tay C, Itskovitz-Eldor J, et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab. 2002;87:709\u201315.","journal-title":"J Clin Endocrinol Metab"},{"key":"990_CR29","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1210\/jc.2015-2332","volume":"100","author":"A Abbara","year":"2015","unstructured":"Abbara A, Jayasena CN, Christopoulos G, Narayanaswamy S, Izzi-Engbeaya C, Nijher GMK, et al. Efficacy of kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy. J Clin Endocrinol Metab. 2015;100:3322\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"990_CR30","doi-asserted-by":"crossref","unstructured":"Griesinger G, Schultz L, Bauer T, Broessner A. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a \u201cfreeze-all\u201d strategy: a prospective multicentric study. Fertil. Steril. 2011.","DOI":"10.1016\/j.fertnstert.2011.01.163"},{"key":"990_CR31","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.fertnstert.2014.01.019","volume":"101","author":"HM Fatemi","year":"2014","unstructured":"Fatemi HM, Popovic-Todorovic B, Humaidan P, Kol S, Banker M, Devroey P, et al. Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and \u201cfreeze-all\u201d approach in GnRH antagonist protocol. Fertil Steril. 2014;101:1008\u201311.","journal-title":"Fertil Steril"},{"key":"990_CR32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.rbmo.2014.07.022","volume":"29","author":"AS Gurbuz","year":"2014","unstructured":"Gurbuz AS, Gode F, Ozcimen N, Isik AZ. Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases. Reprod BioMed Online. 2014;29:541\u20134.","journal-title":"Reprod BioMed Online"},{"key":"990_CR33","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.rbmo.2014.05.012","volume":"29","author":"LP Ling","year":"2014","unstructured":"Ling LP, Phoon JWL, Lau MSK, Chan JKY, Viardot-Foucault V, Tan TY, et al. GnRH agonist trigger and ovarian hyperstimulation syndrome: relook at \u2018freeze-all strategy\u2019. Reprod BioMed Online. 2014;29:392\u20134.","journal-title":"Reprod BioMed Online"},{"key":"990_CR34","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/1471-0528.12572","volume":"121","author":"GT Lainas","year":"2014","unstructured":"Lainas GT, Kolibianakis EM, Sfontouris IA, Zorzovilis IZ, Petsas GK, Lainas TG, et al. Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome. BJOG. 2014;121:848\u201355.","journal-title":"BJOG"},{"key":"990_CR35","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1472-6483(10)60366-5","volume":"15","author":"TG Lainas","year":"2007","unstructured":"Lainas TG, Sfontouris IA, Zorzovilis IZ, Petsas GK, Lainas GT, Kolibianakis EM. Management of severe early ovarian hyperstimulation syndrome by re-initiation of GnRH antagonist. Reprod BioMed Online. 2007;15:408\u201312.","journal-title":"Reprod BioMed Online"},{"key":"990_CR36","first-page":"829","volume":"96","author":"CD Chen","year":"1997","unstructured":"Chen CD, Wu MY, Chao KH, Chen SU, Ho HN, Yang YS. Serum estradiol level and oocyte number in predicting severe ovarian hyperstimulation syndrome. J Formos Med Assoc. 1997;96:829\u201334.","journal-title":"J Formos Med Assoc"},{"key":"990_CR37","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.fertnstert.2003.06.016","volume":"81","author":"A D\u2019Angelo","year":"2004","unstructured":"D\u2019Angelo A, Davies R, Salah E, Nix BA, Amso NN. Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study. Fertil Steril. 2004;81:332\u20136.","journal-title":"Fertil Steril"},{"key":"990_CR38","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","volume":"101","author":"RG Steward","year":"2014","unstructured":"Steward RG, Lan L, Shah AA, Yeh JS, Price TM, Goldfarb JM, et al. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertil Steril. 2014;101:967\u201373.","journal-title":"Fertil Steril"},{"key":"990_CR39","doi-asserted-by":"crossref","unstructured":"Golan A, Ron-El R, Herman A. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989.","DOI":"10.1097\/00006254-198906000-00004"},{"key":"990_CR40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1949","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1949;3:32\u20135.","journal-title":"Cancer"},{"key":"990_CR41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0015-0282(16)59109-2","volume":"47","author":"J Blankstein","year":"1987","unstructured":"Blankstein J, Shalev J, Saadon T, Kukia EE, Rabinovici J, Pariente C, et al. Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles. Fertil Steril. 1987;47:597\u2013602.","journal-title":"Fertil Steril"},{"key":"990_CR42","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/oxfordjournals.humrep.a137469","volume":"6","author":"A Delvigne","year":"1991","unstructured":"Delvigne A, Vandromme J, Barlow P, Lejeune B, Leroy F. Are there predictive criteria of complicated ovarian hyperstimulation in IVF? Hum Reprod. 1991;6:959\u201362.","journal-title":"Hum Reprod"},{"key":"990_CR43","doi-asserted-by":"crossref","first-page":"32-2","DOI":"10.1186\/1477-7827-10-32","volume":"10","author":"K Fiedler","year":"2012","unstructured":"Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol. 2012;10:32-2.","journal-title":"Reprod Biol Endocrinol"},{"key":"990_CR44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0002-9378(88)90523-6","volume":"159","author":"D Navot","year":"1988","unstructured":"Navot D, Relou A, Birkenfeld A, Rabinowitz R, Brzezinski A, Margalioth EJ. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 1988;159:210\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"990_CR45","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10815-011-9627-4","volume":"28","author":"P Ocal","year":"2011","unstructured":"Ocal P, Sahmay S, Cetin M, Irez T, Guralp O, Cepni I. Serum anti-M\u00fcllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles. J Assist Reprod Genet. 2011;28:1197\u2013203.","journal-title":"J Assist Reprod Genet"},{"key":"990_CR46","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/humrep\/12.4.869","volume":"12","author":"J B\u00f3dis","year":"1997","unstructured":"B\u00f3dis J, T\u00f6r\u00f6k A, Tinneberg HR. LH\/FSH ratio as a predictor of ovarian hyperstimulation syndrome. Hum Reprod. 1997;12:869\u201370.","journal-title":"Hum Reprod"},{"key":"990_CR47","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/oxfordjournals.humrep.a019451","volume":"11","author":"B Danninger","year":"1996","unstructured":"Danninger B, Brunner M, Obruca A, Feichtinger W. Prediction of ovarian hyperstimulation syndrome by ultrasound volumetric assessment [corrected] of baseline ovarian volume prior to stimulation. Hum Reprod. 1996;11:1597\u20139.","journal-title":"Hum Reprod"},{"key":"990_CR48","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/oxfordjournals.humrep.a137770","volume":"7","author":"O Gustafson","year":"1992","unstructured":"Gustafson O, Carlstr\u00f6m K, Nylund L. Androstenedione as a predictor of ovarian hyperstimulation syndrome. Hum Reprod. 1992;7:918\u201321.","journal-title":"Hum Reprod"},{"key":"990_CR49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/dem254","volume":"23","author":"T-H Lee","year":"2008","unstructured":"Lee T-H, Liu C-H, Huang C-C, Wu Y-L, Shih Y-T, Ho H-N, et al. Serum anti-M\u00fcllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008;23:160\u20137.","journal-title":"Hum Reprod"},{"key":"990_CR50","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2146\/ajhp070566","volume":"65","author":"P Aramwit","year":"2008","unstructured":"Aramwit P, Pruksananonda K, Kasettratat N, Jammeechai K. Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization. Am J Health Syst Pharm. 2008;65:1148\u201353.","journal-title":"Am J Health Syst Pharm"},{"key":"990_CR51","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0015-0282(99)00090-4","volume":"71","author":"A Enskog","year":"1999","unstructured":"Enskog A, Henriksson M, Unander M, Nilsson L, Br\u00e4nnstr\u00f6m M. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 1999;71:808\u201314.","journal-title":"Fertil Steril"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-017-0990-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-017-0990-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-017-0990-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T01:52:27Z","timestamp":1569808347000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-017-0990-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["990"],"URL":"https:\/\/doi.org\/10.1007\/s10815-017-0990-7","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,14]]}}}